A 2023 study of more than 17,000 patients published in the New England Journal of Medicine found that semaglutide reduced the risk of major cardiovascular events including heart attack, stroke and cardiovascular death by about 20% in overweight or obese adults who already have cardiovascular disease but not diabetes
Whether any prescription medication, compounded or branded, is clinically appropriate has to be worked out with a licensed provider based on your own circumstances - not decided by this article or by Zevay's marketing
You also need to note that the FDA approves Semaglutide to treat type 2 diabetes
Her approach is rooted in evidence-based planning, analytical assessment, and sustainable habit development to enhance overall health and well-being
Improved digestion of FODMAPs : These enzymes help in the breakdown of fermentable oligo-, di-, mono-saccharides and polyols, which are difficult for some people to digest